Background: No previous studies have examined predictive factors for chronic pouchitis after ileal pouch-anal anastomosis (IPAA) for ulcerative colitis (UC) with consideration of changes in pouchitis subtypes during follow-up. This study evaluated the independent predictive factors for chronic pouchitis. Methods: A total of 244 consecutive patients who underwent IPAA were enrolled. We assessed the possible associations between pouchitis and clinical factors using Cox proportional hazard regression. Results: 231 patients met the inclusion criteria. 66 (28.5%) patients developed pouchitis. In 9 of 44 (20.4%) patients, antibiotic-responsive pouchitis at the first episode changed into chronic pouchitis after the occurrence of a subsequent episode. The median duration from occurrence of antibiotic-responsive pouchitis to alteration into chronic pouchitis was 502 (range 147-1,697) days. Overall pouchitis was finally classified into 35 acute pouchitis and 31 chronic pouchitis cases. Multivariate analysis revealed that a ≥7.5-g cumulative steroid dose before colectomy and a ≥500-mg monthly steroid dose just before colectomy were significant predictive factors for chronic pouchitis (p = 0.0001 and 0.0095, respectively). Conclusion: Patients with UC and a higher cumulative steroid dose before colectomy or higher monthly steroid dose just before colectomy may have a predictive factor for developing chronic pouchitis.

1.
Shen B, Fazio VW, Remzi FH, Delaney CP, Bennett AE, Achkar JP, Brzezinski A, Khandwala F, Liu W, Bambrick ML, Bast J, Lashner B: Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses. Am J Gastroenterol 2005;100:93-101.
[PubMed]
2.
Penna C, Dozois R, Tremaine W, Sandborn W, LaRusso N, Schleck C, Ilstrup D: Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996;38:234-239.
[PubMed]
3.
Fazio VW, Ziv Y, Church JM, Oakley JR, Lavery IC, Milsom JW, Schroeder TK: Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 1995;222:120-127.
[PubMed]
4.
Ferrante M, Declerck S, Coopmans T, De Hertogh G, Van Assche G, Penninckx F, Rutgeerts P, Geboes K, D'Hoore A, Vermeire S: Development of pouchitis following ileal pouch-anal anastomosis for ulcerative colitis: a role for serological markers and microbial pattern recognition receptor genes. J Crohns Colitis 2008;2:142-151.
[PubMed]
5.
Shen B: Acute and chronic pouchitis - pathogenesis, diagnosis and treatment. Nat Rev Gastroenterol Hepatol 2012;9:323-333.
[PubMed]
6.
Becker JM, Stucchi AF, Bryant DE: How do you treat refractory pouchitis and when do you decide to remove the pouch? Inflamm Bowel Dis 1998;4:167-169; discussion 170-171.
[PubMed]
7.
Simchuk EJ, Thirlby RC: Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomoses. World J Surg 2000;24:851-856.
[PubMed]
8.
Abdelrazeq AS, Kandiyil N, Botterill ID, Lund JN, Reynolds JR, Holdsworth PJ, Leveson SH: Predictors for acute and chronic pouchitis following restorative proctocolectomy for ulcerative colitis. Colorectal Dis 2008;10:805-813.
[PubMed]
9.
Lohmuller JL, Pemberton JH, Dozois RR, Ilstrup D, van Heerden J: Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990;211:622-627; discussion 627-629.
[PubMed]
10.
Stahlberg D, Gullberg K, Liljeqvist L, Hellers G, Lofberg R: Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum 1996;39:1012-1018.
[PubMed]
11.
Hata K, Watanabe T, Shinozaki M, Nagawa H: Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis. Scand J Gastroenterol 2003;38:1055-1058.
[PubMed]
12.
Achkar JP, Al-Haddad M, Lashner B, Remzi FH, Brzezinski A, Shen B, Khandwala F, Fazio V: Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol 2005;3:60-66.
[PubMed]
13.
Fleshner P, Ippoliti A, Dubinsky M, Ognibene S, Vasiliauskas E, Chelly M, Mei L, Papadakis KA, Landers C, Targan S: A prospective multivariate analysis of clinical factors associated with pouchitis after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2007;5:952-958; quiz 887.
[PubMed]
14.
Hoda KM, Collins JF, Knigge KL, Deveney KE: Predictors of pouchitis after ileal pouch-anal anastomosis: a retrospective review. Dis Colon Rectum 2008;51:554-560.
[PubMed]
15.
Uchino M, Ikeuchi H, Matsuoka H, Bando T, Takesue Y, Tomita N: Clinical features and management of pouchitis in Japanese ulcerative colitis patients. Surg Today 2012 (E-pub ahead of print).
16.
Pardi DS, D'Haens G, Shen B, Campbell S, Gionchetti P: Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis 2009;15:1424-1431.
[PubMed]
17.
Schmidt CM, Lazenby AJ, Hendrickson RJ, Sitzmann JV: Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg 1998;227:654-662; discussion 663-665.
[PubMed]
18.
Hashavia E, Dotan I, Rabau M, Klausner JM, Halpern Z, Tulchinsky H: Risk factors for chronic pouchitis after ileal pouch-anal anastomosis: a prospective cohort study. Colorectal Dis 2012;14:1365-1371.
[PubMed]
19.
Yu ED, Shao Z, Shen B: Pouchitis. World J Gastroenterol 2007;13:5598-5604.
[PubMed]
20.
Suzuki H, Ogawa H, Shibata C, Haneda S, Watanabe K, Takahashi K, Funayama Y, Sasaki I: The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis. Dis Colon Rectum 2012;55:330-336.
[PubMed]
21.
Shen B, Achkar JP, Connor JT, Ormsby AH, Remzi FH, Bevins CL, Brzezinski A, Bambrick ML, Fazio VW, Lashner BA: Modified Pouchitis Disease Activity Index: a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum 2003;46:748-753.
[PubMed]
22.
Fleshner P, Ippoliti A, Dubinsky M, Vasiliauskas E, Mei L, Papadakis KA, Rotter JI, Landers C, Targan S: Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol 2008;6:561-568.
[PubMed]
23.
Kalkan IH, Dagli U, Onder FO, Tunc B, Oztas E, Ulker A, Sasmaz N: Evaluation of preoperative predictors of development of pouchitis after ileal-pouch-anastomosis in ulcerative colitis. Clin Res Hepatol Gastroenterol 2012;36:622-627.
24.
Fleshner PR, Vasiliauskas EA, Kam LY, Fleshner NE, Gaiennie J, Abreu-Martin MT, Targan SR: High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001;49:671-677.
[PubMed]
25.
Shen B, Fazio VW, Remzi FH, Brzezinski A, Bennett AE, Lopez R, Hammel JP, Achkar JP, Bevins CL, Lavery IC, Strong SA, Delaney CP, Liu W, Bambrick ML, Sherman KK, Lashner BA: Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis. Clin Gastroenterol Hepatol 2006;4:81-89; quiz 82-83.
[PubMed]
26.
Kuisma J, Jarvinen H, Kahri A, Farkkila M: Factors associated with disease activity of pouchitis after surgery for ulcerative colitis. Scand J Gastroenterol 2004;39:544-548.
[PubMed]
27.
Aisenberg J, Legnani PE, Nilubol N, Cobrin GM, Ellozy SH, Hegazi RA, Yager J, Bodian C, Gorfine SR, Bauer JJ, Plevy SE, Sachar DB: Are pANCA, ASCA, or cytokine gene polymorphisms associated with pouchitis? Long-term follow-up in 102 ulcerative colitis patients. Am J Gastroenterol 2004;99:432-441.
[PubMed]
28.
Carter MJ, Di Giovine FS, Cox A, Goodfellow P, Jones S, Shorthouse AJ, Duff GW, Lobo AJ: The interleukin-1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. Gastroenterology 2001;121:805-811.
[PubMed]
29.
Meier CB, Hegazi RA, Aisenberg J, Legnani PE, Nilubol N, Cobrin GM, Duerr RH, Gorfine SR, Bauer JJ, Sachar DB, Plevy SE: Innate immune receptor genetic polymorphisms in pouchitis: is CARD15 a susceptibility factor? Inflamm Bowel Dis 2005;11:965-971.
[PubMed]
30.
Mowschenson PM, Critchlow JF, Peppercorn MA: Ileoanal pouch operation: long-term outcome with or without diverting ileostomy. Arch Surg 2000;135:463-465; discussion 465-466.
[PubMed]
31.
Hurst RD, Chung TP, Rubin M, Michelassi F: The implications of acute pouchitis on the long-term functional results after restorative proctocolectomy. Inflamm Bowel Dis 1998;4:280-284.
[PubMed]
32.
Shinozaki M, Suzuki K, Sawada T, Tsuno N, Higuchi Y, Muto T: Steroid complications and surgery in intractable ulcerative colitis. J Gastroenterol 1998;33:196-200.
[PubMed]
33.
Fukushima K, Fujii H, Yamamura T, Sugita A, Kameoka S, Nagawa H, Futami K, Watanabe T, Hatakeyama K, Sawada T, Yoshioka K, Kusunoki M, Konishi F, Watanabe M, Takahashi K, Ogawa H, Funayama Y, Hibi T, Sasaki I: Pouchitis atlas for objective endoscopic diagnosis. J Gastroenterol 2007;42:799-806.
[PubMed]
You do not currently have access to this content.